Correlation Between Matthews India and Cns Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Matthews India and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Matthews India and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Matthews India Fund and Cns Pharmaceuticals, you can compare the effects of market volatilities on Matthews India and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Matthews India with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Matthews India and Cns Pharmaceuticals.

Diversification Opportunities for Matthews India and Cns Pharmaceuticals

-0.48

Correlation Coefficient

Matthews India  Cns Pharmaceuticals

Very good diversification

The 3 months correlation between Matthews and Cns is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Matthews India Fund and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Matthews India is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Matthews India Fund are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Matthews India i.e., Matthews India and Cns Pharmaceuticals go up and down completely randomly.

Pair Corralation between Matthews India and Cns Pharmaceuticals

Assuming the 90 days horizon Matthews India Fund is expected to generate 0.1 times more return on investment than Cns Pharmaceuticals. However, Matthews India Fund is 9.79 times less risky than Cns Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Cns Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest  2,359  in Matthews India Fund on February 17, 2025 and sell it today you would earn a total of  217.00  from holding Matthews India Fund or generate 9.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Matthews India Fund  vs.  Cns Pharmaceuticals

Matthews India

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Matthews India Fund are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Matthews India may actually be approaching a critical reversion point that can send shares even higher in June 2025.

Cns Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in June 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Matthews India and Cns Pharmaceuticals

The main advantage of trading using opposite Matthews India and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Matthews India position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.

The idea behind Matthews India Fund and Cns Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.